Home » Topics » Disease categories and therapies » Immune

Immune
RSS

ImmuneRegen to study Viprovex with Tamiflu

March 5, 2007

Neumune increases survival in primates with acute radiation syndrome

March 2, 2007

Accentia acquires rights to Revimmune

March 2, 2007

Atorvastatin to be tested in new clinical trial for systemic lupus erythematosus

March 1, 2007

Mepolizumab lowers blood eosinophils and reduces steroid use in hypereosinophilic syndrome

Feb. 28, 2007

FK-506 Modified Release recommended for approval in Europe

Feb. 27, 2007

Virus-like particle seasonal influenza vaccine induces broad immune responses in vivo

Feb. 27, 2007

Novel therapeutic agents for transplant rejection disclosed by Astellas

Feb. 22, 2007

University of Texas researchers study chlamydial prevention vaccine

Feb. 21, 2007

WHO awards prequalification status to Rotarix

Feb. 19, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...